X-Linked Adrenal Hypoplasia Congenita in a Boy due to a Novel Deletion of the Entire NR0B1 (DAX1) and MAGEB1–4 Genes

X-linked Adrenal Hypoplasia Congenita (AHC) is caused by deletions or point mutations in the NR0B1 (DAX1) gene. We present a boy with AHC who came at the age of 25 days in a severe state due to prolonged vomiting and progressive dehydration. Laboratory studies showed prominent hyponatremia and hyperkaliemia but not hypoglycemia. Primary adrenal insufficiency was confirmed with low serum cortisol levels and high plasma ACTH levels. Hydrocortisone therapy combined with saline and glucose infusions was started immediately after blood collection. Two exons of the NR0B1 (DAX1) gene were impossible to amplify using the standard PCR method. Array CGH was used to confirm the putative copy-number variation of NR0B1 (DAX1) revealing a novel hemizygous deletion encompassing the entire NR0B1 (DAX1) gene together with the MAGEB genes. This genetic defect was also present in heterozygosity in the patient's mother. We show that NR0B1 (DAX1) gene analysis is important for confirmation of AHC diagnosis and highlights the role of genetic counseling in families with AHC patients, particularly those with X chromosome microdeletions, covering more than NR0B1 (DAX1) alone. We hope that further clinical follow-up of this patient and his family will shed a new light on the role of MAGEB genes.

[1]  A. Rojek,et al.  A novel mutation in the NR0B1 (DAX1) gene in a large family with two boys affected by congenital adrenal hypoplasia , 2002, HORMONES.

[2]  A. Rojek,et al.  NR0B1 (DAX1) mutations in patients affected by congenital adrenal hypoplasia with growth hormone deficiency as a new finding , 2013, Journal of Applied Genetics.

[3]  W. Marsden.  I and J , 2012 .

[4]  E. Lalli,et al.  Gonadotropin-Dependent Precocious Puberty in a Patient with X-Linked Adrenal Hypoplasia Congenita Caused by a Novel DAX-1 Mutation , 2010, Hormone Research in Paediatrics.

[5]  P. Lai,et al.  A Case of X-Linked Adrenal Hypoplasia Congenita, Central Precocious Puberty and Absence of the DAX-1 Gene: Implications for Pubertal Regulation , 2009, Hormone Research in Paediatrics.

[6]  L. Boyes,et al.  Skewed X inactivation is associated with phenotype in a female with adrenal hypoplasia congenita , 2008, Journal of Medical Genetics.

[7]  R. Sinke,et al.  An amino-terminal DAX1 (NROB1) missense mutation associated with isolated mineralocorticoid deficiency. , 2007, The Journal of clinical endocrinology and metabolism.

[8]  J. Jameson,et al.  Analysis of DAX1 (NR0B1) and steroidogenic factor-1 (NR5A1) in children and adults with primary adrenal failure: ten years' experience. , 2006, The Journal of clinical endocrinology and metabolism.

[9]  K. Niakan,et al.  DAX1 origin, function, and novel role. , 2005, Molecular genetics and metabolism.

[10]  H. Yoo,et al.  Identification of Novel Mutations of the DAX-1 Gene in Patients with X-Linked Adrenal Hypoplasia Congenita , 2005, Hormone Research in Paediatrics.

[11]  E. McCabe,et al.  NR0B1A: an alternatively spliced form of NR0B1. , 2004, Molecular genetics and metabolism.

[12]  H. Sugimura,et al.  Splice‐site genetic polymorphism of the human kallikrein 12 (KLK12) gene correlates with no substantial expression of KLK12 protein having serine protease activity , 2004, Human mutation.

[13]  E. McCabe,et al.  Molecular mechanisms of DAX1 action. , 2004, Molecular genetics and metabolism.

[14]  K. Niakan,et al.  IL1RAPL1 is associated with mental retardation in patients with complex glycerol kinase deficiency who have deletions extending telomeric of DAX1 , 2004, Human mutation.

[15]  K. Umesono,et al.  LXXLL-Related Motifs in Dax-1 Have Target Specificity for the Orphan Nuclear Receptors Ad4BP/SF-1 and LRH-1 , 2003, Molecular and Cellular Biology.

[16]  John C Achermann,et al.  An alternate translation initiation site circumvents an amino-terminal DAX1 nonsense mutation leading to a mild form of X-linked adrenal hypoplasia congenita. , 2003, The Journal of clinical endocrinology and metabolism.

[17]  A. Latronico,et al.  Adrenocorticotropin-dependent precocious puberty of testicular origin in a boy with X-linked adrenal hypoplasia congenita due to a novel mutation in the DAX1 gene. , 2001, The Journal of clinical endocrinology and metabolism.

[18]  E. Wiltshire,et al.  Variable Presentation of X-linked Adrenal Hypoplasia Congenita , 2001, Journal of pediatric endocrinology & metabolism : JPEM.

[19]  M. Bertrand,et al.  An overview of the MAGE gene family with the identification of all human members of the family. , 2001, Cancer research.

[20]  M. Ito,et al.  Missense mutations cluster within the carboxyl-terminal region of DAX-1 and impair transcriptional repression. , 2001, The Journal of clinical endocrinology and metabolism.

[21]  J. Jameson,et al.  Presymptomatic diagnosis of X-linked adrenal hypoplasia congenita by analysis of DAX1. , 2000, The Journal of pediatrics.

[22]  B. Vaidya,et al.  Recent advances in the molecular genetics of congenital and acquired primary adrenocortical failure , 2000, Clinical endocrinology.

[23]  Dirk E. Smith,et al.  Identification and Characterization of Two Members of a Novel Class of the Interleukin-1 Receptor (IL-1R) Family , 2000, The Journal of Biological Chemistry.

[24]  K. Ohe,et al.  Orphan Receptor DAX-1 Is a Shuttling RNA Binding Protein Associated with Polyribosomes via mRNA , 2000, Molecular and Cellular Biology.

[25]  A. Tabarin,et al.  A novel mutation in DAX1 causes delayed-onset adrenal insufficiency and incomplete hypogonadotropic hypogonadism. , 2000, The Journal of clinical investigation.

[26]  T. Boon,et al.  Shared tumor-specific antigens , 2000 .

[27]  T. Born,et al.  Identification and characterization of two members of a novel class of the interleukin-1 receptor (IL-1R) family. Delineation of a new class of IL-1R-related proteins based on signaling. , 2000, The Journal of biological chemistry.

[28]  P. Donohoue,et al.  Clinical and functional effects of mutations in the DAX-1 gene in patients with adrenal hypoplasia congenita. , 1999, The Journal of clinical endocrinology and metabolism.

[29]  W. Sippell,et al.  Congenital adrenal hypoplasia: clinical spectrum, experience with hormonal diagnosis, and report on new point mutations of the DAX-1 gene. , 1998, The Journal of clinical endocrinology and metabolism.

[30]  A. Grüters,et al.  Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans , 1998, Nature Genetics.

[31]  J. Nakae,et al.  Three novel mutations and a de novo deletion mutation of the DAX-1 gene in patients with X-linked adrenal hypoplasia congenita. , 1997, The Journal of clinical endocrinology and metabolism.

[32]  W. Crowley,et al.  Adrenal hypoplasia congenita with hypogonadotropic hypogonadism: evidence that DAX-1 mutations lead to combined hypothalmic and pituitary defects in gonadotropin production. , 1996, The Journal of clinical investigation.

[33]  A. Monaco,et al.  Mutations in the DAX-1 gene give rise to both X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism , 1994, Nature.

[34]  A. Monaco,et al.  An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita , 1994, Nature.

[35]  W. Seltzer,et al.  Congenital adrenal hypoplasia, Duchenne muscular dystrophy, and glycerol kinase deficiency: importance of laboratory investigations in delineating a contiguous gene deletion syndrome. , 1994, Clinical chemistry.

[36]  K. Worley,et al.  A dosage sensitive locus at chromosome Xp21 is involved in male to female sex reversal , 1994, Nature Genetics.

[37]  T. Ogihara,et al.  [Congenital adrenal hypoplasia]. , 1993, Ryoikibetsu shokogun shirizu.

[38]  S. Patil,et al.  Duchenne muscular dystrophy, glycerol kinase deficiency, and adrenal insufficiency associated with Xp21 interstitial deletion. , 1986, The Journal of pediatrics.

[39]  A. Ossipov,et al.  Duchenne muscular dystrophy , 2004 .